Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from HOYA ( (JP:7741) ).
HOYA has disclosed that it was notified of a shareholder derivative lawsuit filed in the Tokyo District Court against seven current and former directors and executive officers. The suit, brought by an individual shareholder, seeks ¥23,624 million in damages related to alleged illegal treasury stock acquisitions conducted in 2016 that purportedly exceeded the distributable amount under Japan’s Companies Act.
The company said it has already issued the legally required electronic public notice regarding the case and emphasized that the claim targets individuals rather than the corporate entity itself. HOYA currently believes the lawsuit will not affect its business performance, but has pledged to make prompt disclosures if any material developments or impacts requiring announcement arise.
The most recent analyst rating on (JP:7741) stock is a Buy with a Yen31500.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.
More about HOYA
HOYA CORPORATION is a Japanese manufacturer listed on the TSE Prime Market under code 7741, operating across optical and healthcare-related businesses. The company’s portfolio typically spans products such as optical lenses, medical endoscopes, and related technologies, serving both consumer and institutional markets domestically and overseas.
Average Trading Volume: 902,723
Technical Sentiment Signal: Buy
Current Market Cap: Yen9155B
Learn more about 7741 stock on TipRanks’ Stock Analysis page.